Clinical Trials
2 trialsNCT02324296 2025-06-11
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
Azienda USL Reggio Emilia - IRCCS
Completed
NCT01752517 2012-12-19
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Peking Union Medical College Hospital
Unknown